I MAB's ticker is IMAB and the CUSIP is 44975P103. A total of 49 filers reported holding I MAB in Q3 2023. The put-call ratio across all filers is 1.51 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,122 | -55.9% | 850,000 | 0.0% | 0.05% | -39.2% |
| Q2 2023 | $2,542 | -13.6% | 850,000 | 0.0% | 0.08% | -54.9% |
| Q1 2023 | $2,941 | -17.2% | 850,000 | 0.0% | 0.18% | -11.6% |
| Q4 2022 | $3,553 | -99.9% | 850,000 | 0.0% | 0.20% | +36.6% |
| Q3 2022 | $3,409,000 | -64.5% | 850,000 | 0.0% | 0.14% | -71.7% |
| Q2 2022 | $9,605,000 | -30.4% | 850,000 | 0.0% | 0.51% | -11.2% |
| Q1 2022 | $13,804,000 | -65.7% | 850,000 | 0.0% | 0.58% | -47.1% |
| Q4 2021 | $40,282,000 | -32.6% | 850,000 | +3.0% | 1.09% | -18.3% |
| Q3 2021 | $59,804,000 | -5.0% | 825,000 | +10.0% | 1.34% | +4.7% |
| Q2 2021 | $62,963,000 | +73.2% | 750,000 | 0.0% | 1.28% | +99.1% |
| Q1 2021 | $36,353,000 | +6.3% | 750,000 | +3.4% | 0.64% | -12.5% |
| Q4 2020 | $34,184,000 | +0.3% | 725,000 | 0.0% | 0.73% | -11.4% |
| Q3 2020 | $34,097,000 | +251.6% | 725,000 | +123.8% | 0.83% | +205.5% |
| Q2 2020 | $9,697,000 | +113.1% | 324,000 | -7.4% | 0.27% | +41.1% |
| Q1 2020 | $4,550,000 | – | 350,000 | – | 0.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sage Partners Ltd | 2,054 | $23,000 | 100.00% |
| Cederberg Capital Ltd | 2,215,385 | $25,034,000 | 6.63% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 6,232 | $553,000,000 | 5.77% |
| IvyRock Asset Management (HK) Ltd | 613,356 | $6,931,000 | 4.38% |
| Zeal Asset Management Ltd | 194,538 | $2,060,000 | 4.25% |
| EDBI Pte Ltd | 222,136 | $2,510,000 | 2.33% |
| HHLR ADVISORS, LTD. | 7,182,850 | $81,166,000 | 1.74% |
| Old Well Partners, LLC | 125,325 | $1,416,000 | 1.13% |
| ARMISTICE CAPITAL, LLC | 3,324,000 | $37,561,000 | 0.66% |
| Maso Capital Partners Ltd | 100,000 | $1,130,000 | 0.64% |